SAB Biotherapeutics, Inc 10-K for FY2025
SAB Biotherapeutics, Inc. (SABS)
10-K
2026-03-09
For: 2025-12-31
View Original
Added on
April 10, 2026
About this 10-K
SAB Biotherapeutics, Inc filed this 10-K on March 9, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $1.32M a year earlier
- Net income
- $13.27M
- compared with a net loss of $34.11M a year earlier
- Diluted EPS
- -$0.79
- compared with -$3.68 a year earlier